30,486 Shares in Tempus AI, Inc. (NASDAQ:TEM) Bought by Bouvel Investment Partners LLC

Bouvel Investment Partners LLC purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 30,486 shares of the company’s stock, valued at approximately $1,029,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. First Horizon Advisors Inc. purchased a new position in Tempus AI in the 3rd quarter worth $30,000. FNY Investment Advisers LLC purchased a new position in Tempus AI during the 4th quarter valued at about $67,000. Vestor Capital LLC bought a new position in Tempus AI during the 3rd quarter valued at approximately $153,000. Stifel Financial Corp purchased a new stake in Tempus AI in the third quarter worth $218,000. Finally, Sandia Investment Management LP purchased a new position in shares of Tempus AI in the 2nd quarter valued at approximately $136,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Loop Capital dropped their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and lifted their price target for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Bank of America raised their target price on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research note on Friday, December 13th. Needham & Company LLC reissued a “buy” rating and issued a $56.00 price target on shares of Tempus AI in a research report on Tuesday. Finally, Piper Sandler reaffirmed a “neutral” rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, Tempus AI has an average rating of “Moderate Buy” and a consensus target price of $56.36.

Insiders Place Their Bets

In other news, CEO Eric P. Lefkofsky sold 187,655 shares of Tempus AI stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $37.54, for a total transaction of $7,044,568.70. Following the transaction, the chief executive officer now owns 9,557,283 shares in the company, valued at $358,780,403.82. This trade represents a 1.93 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Andrew Polovin sold 51,504 shares of Tempus AI stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.39, for a total value of $2,183,254.56. Following the transaction, the executive vice president now owns 246,085 shares in the company, valued at $10,431,543.15. This trade represents a 17.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 865,041 shares of company stock valued at $35,917,673.

Tempus AI Stock Down 0.5 %

TEM stock opened at $34.75 on Friday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $79.49. The stock’s fifty day moving average price is $46.80 and its 200-day moving average price is $47.09.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.